Related Experiment Video

Updated: Aug 28, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.8K

Influence Diagnostics of a Region of Interest in Multi-regional Clinical Trials

Kazuhiko Kuribayashi1, Charlie Cao2

  • 1Biogen Japan Ltd., Tokyo, Japan. kazuhiko.kuribayashi@biogen.com.

Therapeutic Innovation & Regulatory Science
|September 15, 2022
PubMed

Insights

Influence diagnostics offer a novel approach for multi-regional clinical trials (MRCTs) in rare disease drug development. This method assesses a region's impact on overall trial results, overcoming limitations of traditional subgroup analyses, especially with small sample sizes.

Area of Science:

  • Clinical Trials Methodology
  • Biostatistics
  • Drug Development

Background:

  • Multi-regional clinical trials (MRCTs) are crucial for rare disease drug development, facilitating timely subject recruitment.
  • Evaluating the applicability of overall trial results to specific regions is a key objective of MRCTs.
  • Traditional methods using subgroup analyses may be inadequate for rare diseases due to small sample sizes.

Purpose of the Study:

  • To introduce and evaluate influence diagnostics as a method for assessing regional impact in MRCTs.
  • To provide an alternative statistical approach for MRCTs in rare diseases, particularly when dealing with limited data.

Main Methods:

  • Application of influence diagnostics to assess the influence of a specific region on overall MRCT results.
  • Validation through Monte Carlo simulations.
  • Analysis of a real-world multi-regional clinical trial.

Main Results:

  • Influence diagnostics provide a viable method for assessing regional influence in MRCTs.
  • The proposed approach demonstrates effectiveness even with small sample sizes characteristic of rare disease studies.
  • Simulation results support the utility of influence diagnostics.

Conclusions:

  • Influence diagnostics represent a valuable analytical option for MRCTs in rare disease research.
  • This method enhances the evaluation of regional applicability in drug development.
  • The approach offers a robust alternative to traditional subgroup analyses for rare disease trials.
Keywords:
Consistency assessmentICH E17 guidelineInfluence of a region of interestRare disease

More Related Videos

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.7K
Basics of Multivariate Analysis in Neuroimaging Data06:35

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 24, 2010

17.0K

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
7.0K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.2K
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
366
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
162
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
539
Confounding in Epidemiological Studies01:27

Confounding in Epidemiological Studies

Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This...
240